CORTI, STEFANIA PAOLA
CORTI, STEFANIA PAOLA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease
2026 A. Lerario, E. Abati, M. Sciacco, G.P. Comi, V. Desantis, S. D'Amore, A.G. Solimando, R. Ria, S. Corti, F. Spataro
A point-of-care test for miR-129–5p detection at sub-atto molar concentrations exploiting plasmonic pollen probes combined with complementary DNA
2026 L. Pasquardini, R. Pitruzzella, F. Arcadio, M. Rizzuti, V. Melzi, F. Sironi, L. Vanzetti, A. Chiappini, C. Perri, L. Ottoboni, N. Cennamo, S. Corti, L. Zeni
A new MYH2 variant in an Italian patient expanding the clinical spectrum of MYH2-related myopathy
2026 S. Zanotti, D. Ronchi, L. Napoli, M. Ripolone, S. Pagliarani, P. Ciscato, L. Bertolasi, R. Del Bo, F. Magri, D. Velardo, G.P. Comi, S. Corti, M. Sciacco
AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model
2026 E. Pagliari, A. Anastasia, F. Bellandi, M. Garbellini, J. Ongaro, M. Taiana, G.P. Comi, L. Ottoboni, J.A. Sierra-Delgado, S. Likhite, K.C. Meyer, M. Nizzardo, S.P. Corti
Expanding the genetic landscape of Dusty Core Disease: new RYR1 variants in Italian patients
2026 S. Zanotti, F. Magri, S. Salani, L. Napoli, M. Ripolone, S. Pagliarani, D. Ronchi, F. Fortunato, P. Ciscato, D. Cassandrini, F. Fattori, M.G. D'Angelo, E. Albamonte, V. Nigro, M. Sciacco, S. Corti, G.P. Comi, D. Piga
High Prevalence of SOD1 Pathogenic Variants in the UK Biobank: Implications for Early Intervention in Amyotrophic Lateral Sclerosis
2026 D. Gagliardi, C. Villella, M. Zanovello, V. Iacobelli, S. Corti, G.P. Comi, P. Fratta, H. Houlden, A. Tucci, D. Ronchi
Lithium ameliorates neural differentiation restoring cell death balance in Cornelia de Lange syndrome 2D and 3D models
2026 C. Parodi, A. Lettieri, P. Grazioli, E. Di Fede, S. Grassi, E. Taci, A. Toscani, S. Prioni, S. Rebellato, E.A. Colombo, S. Rasetti, A. Cutarelli, M. Mariani, S. Corti, P. Finelli, A. Prinetti, G. Fazio, A. Selicorni, L. Conti, C. Gervasini, V. Massa
RNA biomarkers in spinal muscular atrophy: enhancing pathogenesis understanding and guiding precision medicine
2026 C. Alberti, A. Berardinelli, G.P. Comi, L. Ottoboni, S. Corti
Regulation of PHOX2B gene expression by the long non-coding natural antisense RNA PHOX2B-AS1
2026 S. Di Lascio, A.L. Cuadros Gamboa, M. Bertocchi, F. Chiesa, F. Cargnin, E. Mosca, P. Pelucchi, V. Tritto, S. Corti, I. Ceccherini, P. Riva, R. Benfante, D. Fornasari
Skeletal muscle in spinal muscular atrophy: Critical insights from pathogenesis to therapeutic strategies
2026 L. Ottoboni, C. Panicucci, G. Magni, D. Gagliardi, M. Ripolone, L. Napoli, M. Moggio, G.P. Comi, C. Bruno, S.P. Corti
Minds and machines: AI's transformative role in human identity and medicine
2026 S. Corti, R. Ferrucci, G.N. Angotzi, A. Arighi, P. Brambilla, E. Buijs, G. Carrafiello, M. Crippa, E. De Momi, P. Del Debbio, R. Folgieri, M. Giachetti, A.B. Giannì, W. Magnoni, S. Marceglia, M. Massimini, D. Stigliani, M. Stocco, A. Tanga, L. Ottoboni, S. Barbieri
Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A
2026 E. Abati, D. Saccomanno, C. Alberti, A. Anastasia, D. Gagliardi, E. Ferri, B. Arosio, G. D Angelo, R. Cima, M.T. Bassi, S. Oldoni, G.P. Comi, P. Rizzo, S.P. Corti
High-plex spatial protein profiling of skeletal muscle biopsies in inflammatory myopathies using the MACSima™ imaging platform: A pilot study
2026 M. Sciacco, D. Velardo, L. Bertolasi, P. Ciscato, G. Castellano, D. Mattinzoli, M. Ikehata, S. Corti, G.P. Comi, S. Zanotti
Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in Italy
2026 S. Corti, G. Gadaleta, I. Bitetti, G. Crescimanno, A. D'Amico, C. Dosi, R. Masson, A.K. Patanella, M.C. Pera, F. Rao, F. Ricci, G. Ricci, B. Risi, E. Roma, L. Ruggiero, M. Sframeli, G. Coratti, M. Pane, V.A. Sansone
Case Report: Incidental late-onset Pompe disease diagnosis in a man with no clinical and instrumental evidence of neuromuscular dysfunction
2025 M. Sciacco, S. Lucchiari, L. Bertolasi, G.P. Comi, S. Corti, D. Ronchi
Advancing personalized spinal muscular atrophy care: matching the right biomarker to the right patient at the right time
2025 S. Corti, L. Ottoboni, V. Sansone
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models
2025 E. Pagliari, M. Taiana, P. Manzini, L. Sali, L. Quetti, L. Bertolasi, S. Oldoni, V. Melzi, G. Comi, S. Corti, M. Nizzardo, F. Rizzo
Decoding inflammatory pathways in spinal muscular atrophy: implications for next-generation therapies
2025 L. Ottoboni, C. Bruno, S. Corti
C9orf72 Repeat Expansion Induces Metabolic Dysfunction in Human iPSC‐Derived Microglia and Modulates Glial‐Neuronal Crosstalk
2025 M. Mearelli, I. Hirschberg, C. Weissleder, C. Giachino, M.J. Pérez, M. Dubroux, F. Provenzano, M. Rizzuti, L. Ottoboni, U. Sheth, T.F. Gendron, S. Corti, M. Deleidi
Intrinsic neuronal resilience as a tool for therapeutic discovery
2025 S. Corti, E. Hedlund